NCT04278391View on ClinicalTrials.gov

"Pharmacokinetics and Safety Between DWJ1421 and DWC201903 in Healthy Male Volunteers"

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 2, 2019

Primary Completion Date

August 10, 2019

Study Completion Date

February 19, 2020

Conditions
Healthy
Interventions
DRUG

DWJ1421

1 tablet administered in fasting condition

DRUG

DWC201903

1 tablet administered in fasting condition

Trial Locations (1)

Unknown

Bundang CHA Medical Center, Seongnam-si

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY